Project leader

Ms. Michaela Bartaun, Mag.
Project leader
Phone:+43 1 890 44 27
Fax:+43 1 890 44 27 9

Project staff

Dr. Terez Sera, PhD
EARL physicist

 

Professor Ronald Boellaard, PhD
Medical physicist, Scientific support for EARL

Institute presentation

The Board of the European Association of Nuclear Medicine (EANM) launched EARL as a 100% subsidiary of EANM in 2006. The major aim of EARL is to enhance the quality of nuclear medicine practice in Europe and to provide a platform for and be the facilitator of multi centric (research) projects. An advisory board, which is composed of the EANM President, the EANM Committee coordinator, the EANM Treasurer, the leader of the EARL task force EU research grants, the EARL project leaders, and the CEOs of EARL, decides on the strategic directions of EARL and its future project plans.
EARL’s experience in set up, performance, logistic coordination, and scientific and commercial exploitation of multi centric research is documented by its successful pilot project, the “Establishment of an European database of [I-123]FP-CIT (DaTSCAN) SPECT scans of healthy controls (ENCDAT), which was performed from 2007 to 2010. Under the leadership of EARL this investigator-initiated study was conducted by 13 institutions (cluster of centres within a “network of excellence”) in 10 European countries. The project consisted of 3 consecutive parts: a) definition of standards for camera qualification, acquisition and processing, b) cross-calibration procedures of gamma cameras with an anthropomorphic phantom, and c) to establish a normal database of FP-CIT scans from more than 150 well controlled healthy subjects, which was successfully commercialised.
In 2010 EARL launched its second key project, the FDG-PET/CT accreditation programme, which followed the publication of “FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0” in the EJNMMI, which is currently being updated. Aim of this highly important project is to ensure similar performance of PET/CT systems within a multi centric setting, to collect data in a standardised manner and therefore allow the sites to compare, exchange and combine FDG-PET/CT findings, including SUVs. The accreditation programme is endorsed by the European Organisation for Research and Treatment of Cancer (EORTC). Until today more than 90 PET/CT centers/100 PET/CT scanners, most of them in Europe, have joined the highly valued programme.
Apart from its strength in the standardization of nuclear medicine imaging procedures, EARL provides (in conjunction with the EANM educational facility) a highly effective infrastructure for training, education, dissemination and commercialization. The well-appointed training and education facility is located in the EANM Headquarter in Vienna. The offices there are most experienced in dissemination via website, newsletter, congress, courses etc. and, furthermore, in dealing with intellectual property rights as well as negotiations for commercial exploitation of results.

The EANM Research Ltd (EARL), Vienna, will coordinate WP 6. Our main tasks within the project will be dissemination as well as support of standardization of imaging and training.

WP6 plays a central role in the interaction of BetaCure partners aiming at building up intersectoral expertise, training of experts within and outside of the consortium and definition and implementation of standards for personalized diagnostics and treatment in CHI and AHH patients. In addition, in order to obtain comparable and quantitative SPECT and PET data of the highest quality, all scanners used for the clinical studies will be calibrated and certified.

  • Training of scientists including training for clinical studies
  • Definition and implementation of standards for the clinical studies including scanner calibration
  • Dissemination of BetaCure results towards the scientific community and the general population with a focus on contact with patient organizations
  • Training of physicians and scientists outside of the consortium
Print
Top